Cargando…
The Role of General Anesthetic Drug Selection in Cancer Outcome
Cancer remains to be the leading cause of death globally. Surgery is a mainstay treatment for solid tumors. Thus, it is critical to optimize perioperative care. Anesthesia is a requisite component for surgical tumor resection, and general anesthesia is given in the vast majority of tumor resection c...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516539/ https://www.ncbi.nlm.nih.gov/pubmed/34660784 http://dx.doi.org/10.1155/2021/2563093 |
_version_ | 1784583825400004608 |
---|---|
author | Yuki, Koichi |
author_facet | Yuki, Koichi |
author_sort | Yuki, Koichi |
collection | PubMed |
description | Cancer remains to be the leading cause of death globally. Surgery is a mainstay treatment for solid tumors. Thus, it is critical to optimize perioperative care. Anesthesia is a requisite component for surgical tumor resection, and general anesthesia is given in the vast majority of tumor resection cases. Because anesthetics are growingly recognized as immunomodulators, it is critical to optimize anesthetic regimens for cancer surgery if the selection can affect outcomes. Here, we reviewed the role of volatile and intravenous anesthesia used for cancer surgery in cancer recurrence. |
format | Online Article Text |
id | pubmed-8516539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-85165392021-10-15 The Role of General Anesthetic Drug Selection in Cancer Outcome Yuki, Koichi Biomed Res Int Review Article Cancer remains to be the leading cause of death globally. Surgery is a mainstay treatment for solid tumors. Thus, it is critical to optimize perioperative care. Anesthesia is a requisite component for surgical tumor resection, and general anesthesia is given in the vast majority of tumor resection cases. Because anesthetics are growingly recognized as immunomodulators, it is critical to optimize anesthetic regimens for cancer surgery if the selection can affect outcomes. Here, we reviewed the role of volatile and intravenous anesthesia used for cancer surgery in cancer recurrence. Hindawi 2021-10-07 /pmc/articles/PMC8516539/ /pubmed/34660784 http://dx.doi.org/10.1155/2021/2563093 Text en Copyright © 2021 Koichi Yuki. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Yuki, Koichi The Role of General Anesthetic Drug Selection in Cancer Outcome |
title | The Role of General Anesthetic Drug Selection in Cancer Outcome |
title_full | The Role of General Anesthetic Drug Selection in Cancer Outcome |
title_fullStr | The Role of General Anesthetic Drug Selection in Cancer Outcome |
title_full_unstemmed | The Role of General Anesthetic Drug Selection in Cancer Outcome |
title_short | The Role of General Anesthetic Drug Selection in Cancer Outcome |
title_sort | role of general anesthetic drug selection in cancer outcome |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516539/ https://www.ncbi.nlm.nih.gov/pubmed/34660784 http://dx.doi.org/10.1155/2021/2563093 |
work_keys_str_mv | AT yukikoichi theroleofgeneralanestheticdrugselectionincanceroutcome AT yukikoichi roleofgeneralanestheticdrugselectionincanceroutcome |